InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Ozawa Clare, Director. Director active across 2 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 12 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €7.7m. History available since 12 May 2021. The latest transaction was disclosed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
11,064 sharesCommon StockSEC:0001209191-23-001088:0
3,573 shares0Common StockSEC:0001209191-22-035067:0
200,213 shares0Common StockSEC:0000899243-22-001359
200,213 shares0Common StockSEC:0000899243-22-001359:0
200,213 shares0Common StockSEC:0000899243-21-049597:0
200,213 shares0Common StockSEC:0000899243-21-049597
303,614 shares@ US$14.632750.0% of flowCommon StockSEC:0000899243-21-040771:0
303,614 shares@ US$14.632750.0% of flowCommon StockSEC:0000899243-21-040771
3,466 shares0Common StockSEC:0001209191-21-039351:0
3,466 shares0Common StockSEC:0001209191-21-039351
320,340 shares0Common StockSEC:0000899243-21-019514
320,340 shares0Common StockSEC:0000899243-21-019514:0
12 of 12 declarations
About Ozawa Clare
Clare Ozawa is a Director at Oyster Point Pharma, Inc. In this role, she participates in the governance of the company, providing her expertise in strategy and biopharmaceuticals. Clare plays a key role in the strategic direction of Oyster Point, a company specializing in developing ophthalmic treatments.
